Skip to content
healthcare.dev

LURASIDONE HYDROCHLORIDE

NDC 65862-953, LURASIDONE HYDROCHLORIDE, tablet, from Aurobindo Pharma Limited.

Product NDC
65862-953
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208045
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-953 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LURASIDONE HYDROCHLORIDE20 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
65862-953-0565862095305500 TABLET in 1 BOTTLE (65862-953-05)
65862-953-306586209533030 TABLET in 1 BOTTLE (65862-953-30)
65862-953-906586209539090 TABLET in 1 BOTTLE (65862-953-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b3e9cc86-0c5c-444f-ab57-f4d1a6865035
  • NADAC price for package 65862095330

    GET /v1/drugs/nadac/65862095330

Use it

Look up 65862-953 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-953 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-953. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.